Search

Your search keyword '"Le Moigne, E."' showing total 184 results
Start Over Author "Le Moigne, E."
184 results on '"Le Moigne, E."'

1. OC 72.4 Risk of Venous Thromboembolism (VTE) in First-Degree Relatives of Patients with VTE Compared with General Population VTE Risk

Author

Robin, S., primary, Nachtergaele, C., additional, Le Mao, R., additional, Espinasse, B., additional, de Moreuil, C., additional, Tromeur, C., additional, Guegan, M., additional, Melac, S., additional, Le Moigne, E., additional, Lacut, K., additional, Delluc, A., additional, Leroyer, C., additional, Kearon, C., additional, and Couturaud, F., additional

Published
2023
Full Text
View/download PDF

3. PB0928 Competing Risks Analysis of Recurrent Venous Thromboembolism (VTE) and Bleeding on Anticoagulation in Patients with Cancer- Associated VTE

Author

Simon, D., primary, Espinasse, B., additional, Le Mao, R., additional, Raj, L., additional, de Moreuil, C., additional, Tromeur, C., additional, Guegan, M., additional, Le Moigne, E., additional, Poulhazan, E., additional, Lacut, K., additional, Leroyer, C., additional, Mahe, I., additional, Nowak, E., additional, and Couturaud, F., additional

Published
2023
Full Text
View/download PDF

5. LB 02.2 Prevention of Symptomatic Venous Thromboembolism with LowMolecular-Weight Heparin in Hospitalized Older Adult Medical Patients: A Randomized Placebo-Controlled Trial

Author

Mottier, D., primary, Girard, P., additional, Couturaud, F., additional, Le Moigne, E., additional, Paleiron, N., additional, Guellec, D., additional, Sanchez, O., additional, Cogulet, V., additional, Laporte, S., additional, Marhic, G., additional, Mismetti, P., additional, Presles, E., additional, Robert-Ebadi, H., additional, Mahe, I., additional, Plaisance, L., additional, Reny, J., additional, Righini, M., additional, and Le Gal, G., additional

Published
2023
Full Text
View/download PDF

6. OC 02.3 OC 02.3 Risk Factors for Severe Postpartum Hemorrhage after Assisted Reproductive Technology: Data from the French HEMOTHEPP Cohort Study

Author

Robin, S., primary, Bouée, S., additional, Anouilh, F., additional, Trémouilhac, C., additional, Drugmanne, G., additional, Le Guillou, M., additional, Blin, A., additional, Bellec, V., additional, Muller, M., additional, Jacquot, M., additional, Tromeur, C., additional, Couturaud, F., additional, Le Moigne, E., additional, Pan-Petesch, B., additional, and de Moreuil, C., additional

Published
2023
Full Text
View/download PDF

10. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score

Author

Bertoletti, L., Robin, P., Jara‐Palomares, L., Tromeur, C., Pastre, J., Prevot‐Bitot, N., Mouneh, T., Le Gal, G., Salaun, P.‐Y., Armand, A., de Boisjolly, J. M., Bordot, A. S., Dambrine, S., Delori, M., Derrien, B., Guillaume, B., Lavigne, C., Loison, J., Pattier, K., Roy, P. M., Barnier, A., Blanc, J. J., Cornily, J. C., Couturaud, O., Delluc, A., Gut‐Gobert, C., Jaffrelot, M., Lacut, K., Leroyer, C., Le Hénaff, M., Le Moigne, E., Mottier, D., Paleiron, N., Pasquier, E., Pennec, P. Y., Quéré, G., Rogé, C., de Saint Martin, L., Belmont, L., Gosset, M., Meyer, G., Mourin, G., Planquette, B., Roux, A., Sanchez, O., Wermert, D., Accassat, S., Bost, V., Buchmuller, A., Décousus, H., Décousus, M., Merah, A., Rivron‐Guillot, K., Robert, F., Tardy, B., and Torris, P.

Published
2017
Full Text
View/download PDF

13. Abortos espontáneos recurrentes

Author

Merviel, P., primary, Hannigsberg, J., additional, Tremouilhac, C., additional, Herrmann, S., additional, Saliou, A.H., additional, Dupré, P.F., additional, De Moreuil, C., additional, Pasquier, E., additional, Le Moigne, E., additional, and Couturaud, F., additional

Published
2021
Full Text
View/download PDF

16. Comparison between transthoracic echocardiography and transcranial Doppler for detection of PFO in patients in the acute phase of a pulmonary embolism. A Post-hoc analysis of EPIC-FOP

Author

Feliachi, S, primary, Le Moigne, E, additional, Le Ven, F, additional, Hoffmann, C, additional, Bressolette, L, additional, Didier, R, additional, Jobic, Y, additional, Gilard, M, additional, Mansourati, J, additional, Leroyer, C, additional, and Couturaud, F, additional

Published
2020
Full Text
View/download PDF

24. Prophylaxie de la maladie veineuse thromboembolique par HBPM en post-partum en pratique : effets indésirables et problèmes rapportés par les patientes. Étude prospective dans deux maternités

Author

Le Moigne, E., primary, Pan-Petesch, B., additional, Tromeur, C., additional, Tremouilhac, C., additional, Jacquot, M., additional, Drugmanne, G., additional, Jolas, S., additional, Delluc, A., additional, Lacut, K., additional, and Mottier, D., additional

Published
2017
Full Text
View/download PDF

27. Augmentation du risque d’accident ischémique cérébral en cas de FOP chez les patients présentant une embolie pulmonaire : l’embolie paradoxale est un mécanisme important. Étude prospective multicentrique EPIC FOP

Author

Le Moigne, E., primary, Ben Salem, D., additional, Jobic, Y., additional, Timsit, S., additional, Delluc, A., additional, Paleiron, N., additional, Tromeur, C., additional, Joseph, T., additional, Hoffmann, C., additional, Le Gal, G., additional, Couturaud, F., additional, and Mottier, D., additional

Published
2017
Full Text
View/download PDF

30. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study

Author

Le Moigne E, Le Gal G, Dominique Mottier, Aurélien Delluc, Zarrin Alavi, Maelenn Gouillou, Cécile Tromeur, Karine Lacut, Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Ottawa Hospital Research Institute [Ottawa] (OHRI)

Subjects
Adult, medicine.medical_specialty, medicine.drug_class, [SDV]Life Sciences [q-bio], Population, 030204 cardiovascular system & hematology, Contraceptives, Oral, Hormonal, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, cohort study, Medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, education, Letters to the Editor, ComputingMilieux_MISCELLANEOUS, Progesterone, Retrospective Studies, Gynecology, education.field_of_study, business.industry, Obstetrics, Retrospective cohort study, Hematology, Venous Thromboembolism, Middle Aged, equipment and supplies, medicine.disease, 3. Good health, Contraception, Embolism, Hormonal contraception, Family planning, Female, Progestins, business, Progestin, Developed country, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Cohort study
Abstract

Choice of contraception after venous thromboembolism (VTE) is challenging because hormonal contraception may increase the risk of recurrent VTE. Estrogen contraception is usually contraindicated in women with a personal history of VTE (category 4, unacceptable health risk according to the World

Published
2015

32. Diagnostic Value of a New Sensitive Membrane Based Technique for Instantaneous D-Dimer Evaluation in Patients with Clinically Suspected Deep Venous Thrombosis

Author

Jean Amiral, Luc Bressollette, Cagnioncle O, Dominique Mottier, JF Abgrall, M Escoffre, Le Moigne E, Christophe Leroyer, Emmanuel Oger, M Grimaux, Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), and CHRU Brest - Service d'Hématologie (CHU-Brest-Hemato)

Subjects
Male, Time Factors, MESH: Reagent Kits, Diagnostic, 030204 cardiovascular system & hematology, MESH: Aged, 80 and over, 0302 clinical medicine, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Ultrasonography, MESH: Aged, Aged, 80 and over, MESH: Middle Aged, medicine.diagnostic_test, MESH: Enzyme-Linked Immunosorbent Assay, Hematology, Middle Aged, MESH: Predictive Value of Tests, 3. Good health, Venous thrombosis, medicine.anatomical_structure, Evaluation Studies as Topic, MESH: Evaluation Studies as Topic, Female, Radiology, MESH: Membranes, Artificial, Adult, medicine.medical_specialty, Adolescent, Venography, MESH: Phlebography, Enzyme-Linked Immunosorbent Assay, Sensitivity and Specificity, Fibrin Fibrinogen Degradation Products, 03 medical and health sciences, MESH: Thrombophlebitis, Predictive Value of Tests, D-dimer, MESH: Fibrin Fibrinogen Degradation Products, medicine, Humans, In patient, cardiovascular diseases, Elisa method, Vein, Aged, MESH: Adolescent, MESH: Humans, Vascular disease, business.industry, MESH: Time Factors, MESH: Adult, Membranes, Artificial, Phlebography, Thrombophlebitis, medicine.disease, MESH: Prospective Studies, MESH: Sensitivity and Specificity, MESH: Male, Reagent Kits, Diagnostic, business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

SummaryBackground: Plasma D-Dimer analysis, using ELISA assays, has demonstrated in previous studies a high sensitivity, suggesting its utility in excluding deep venous thrombosis (DVT). Aim: To assess the performance of a new rapid plasma D-Dimer ELISA measurement in suspected DVT patients with recent clinical signs, not exceeding one week. Methods: A prospective study of patients admitted for a suspected recent DVT. Contrast venography or compression ultrasonography were performed within 24 h of admission. A new membrane based ELISA technique, which uses an immunofiltration and two complementary monoclonal antibodies was tested. Results were expressed as positive or negative. A standard plasma D-Dimer ELISA measurement was also performed. D-Dimer performances were assessed at the end of the study. Results: 265/448 patients had a proven DVT (72 distal, 193 proximal). The sensitivity of the instantaneous method in the diagnosis of overall DVT is 92 ± 3.4% (95% Cl), and specificity is 36.6 ± 6.9%. Positive predictive value is 67.7 ± 4.8% and negative predictive value is 76.1 ± 8.9%. Sensitivity and negative predictive values reach 97.9 and 94.3% in the diagnosis of proximal DVT, but only 76.3 and 79.7% in the diagnosis of distal DVT. Similar results are observed with the standard ELISA method. Conclusion: This new rapid plasma D-Dimer measurement appears highly sensitive, and could substitute the older ELISA methods. Both methods provide lower sensitivity in the case of a distal DVT location.

Published
1997

33. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Author

Agnelli, G, Berkowitz, S, Bounameaux, H, Büller, Hr, Cohen, A, Gallus, A, Lensing, Aw, Misselwitz, F, Haskell, L, Prins, Mh, Raskob, G, Schellong, S, Bauersachs, R, van Bellen, B, Boda, Z, Borris, L, Brenner, B, Brighton, T, Chlumsky, J, Davidson, B, Decousus, H, Eriksson, H, Jacobson, B, Kakkar, A, Kwong, Yl, Lee, Lh, Meijer, K, van der Meer, J, Minar, E, Monreal, M, Piovella, F, Sandset, Pm, Smith, M, Tomkowski, W, Verhamme, P, Wang, Y, Wells, P, Brandjes, D, Mac Gillavry, M, Otten, Hm, Carlsson, A, Laporte, S, Schulman, S, Gent, M, Turpie, A, Martinelli, I, Segers, A, Muhlhofer, E, Tewes, M, Trajanovic, M, Muller, K, Kim, C, Gebel, M, Benson, A, Pap, Af, Godrie, J, Horvat Broecker, A, Spadari, G, Peters Wulf, C, Roig, J, Baker, R, Bianchi, A, Blombery, P, Campbell, P, Carroll, P, Geraghty, R, Chong, B, Ramanathan, S, Archis, C, Coughlin, P, Salem, H, Crispin, P, Dean, M, Soni, R, Denaro, C, Kubler, P, Coghlan, D, Gan, Te, Tran, H, Coleman, C, Jackson, D, Khalafallah, A, Leahy, M, Leyden, M, Leyden, D, Sturtz, C, Mccann, A, Gibbs, H, Mcrae, S, Richards, B, Ward, C, Curnow, J, Baghestanian, M, Erdogmus, B, Samaha, E, Nikoupayan Mofrad, M, Hirschl, M, Sturm, W, Kirchmair, R, Marschang, P, Drexel, H, Mathies, R, Pilger, E, Brodmann, M, Weltermann, A, Buche, M, Demelenne, J, Gustin, M, Hainaut, P, Pothen, L, de Leersnyder, J, Motte, S, Schroë, H, Sprynger, M, Peerlinck, K, Delcroix, M, Vermassen, F, Verstraeten, P, Smet, V, Vossaert, R, Panico, M, Costa, C, Blondal, J, Kovacs, M, Rodger, M, Carrier, M, Wong, T, Bi, J, Chen, Z, Chen, R, Jing, Zc, He, J, Liu, C, Liu, S, Long, S, Ma, Y, Shao, Y, Wang, C, Yang, Yh, Xie, C, Xu, J, Ying, K, Zhihong, L, Hola, D, Jirat, S, Vitovec, M, Kovářová, K, Gilík, J, Dosál, J, Mandakova, E, Matoška, P, Podpera, I, Podperova, M, Spacek, R, Urbanova, R, Tuxen, C, Sukles, K, Pietila, K, Vesanen, M, Achkar, A, Agraou, B, Aquilanti, S, Rifaï, A, Berremili, T, Brisot, D, Brousse, C, Tarodo, P, Bura, A, Amid Lacombe, C, Malloizel, J, Boulon, C, Alavoine, L, Crestani, B, Mismetti, P, Buchmuller, A, Accassat, S, Elias, A, Elias, M, Emmerich, J, Ferrari, E, Guérin, T, Beaka, P, Lacroix, P, Szwebel, Ta, Benhamou, Y, de Maistre, E, Falvo, N, Mahe, I, Meneveau, N, Schiele, F, Meyer, G, Sanchez, O, Planquette, B, Mottier, D, Le Moigne, E, Couturaud, F, Parent, F, Pernod, G, Imbert, B, Elkouri, D, Dary, M, Queguiner, A, Quere, I, Galanaud, Jp, Roy, Pm, de Boisjolly Bonnefoi JM, Schmidt, J, Breuil, N, Heuser, S, Sevestre, Ma, Simoneau, G, Bergmann, Jf, Stephan, D, Trinh Duc, A, Gaillardou, A, Grange, C, Fassier, T, Wahl, D, Baron Von Bilderling, P, Kuhlencordt, P, Beyer Westendorf, J, Halbritter, K, Werth, S, Diehm, C, Lawall, H, Eifrig, B, Espinola Klein, C, Weisser, G, Giannitsis, E, Haering, Hu, Hasslacher, C, Herrmann, T, Hoffmann, U, Czihal, M, Horacek, T, Ibe, M, Bauer, A, Kieback, A, Landgraf, H, Lindhoff Last, E, Malyar, N, Petermann, W, Potratz, J, Ranft, J, Röcken, M, Pomper, L, Frommhold, R, Schwaiblmair, M, Berghaus, T, Taute, B, Lau, Yk, Tse, E, Olah, Z, Farkas, K, Kolossváry, E, Gurzó, M, Kis, E, Kovács, A, Landi, A, Lupkovics, G, Pecsvarady, Z, Riba, M, Sipos, G, Parakh, R, Sembiring, R, Barton, J, Goldstein, L, Gavish, D, Hoffman, R, Hussein, O, Inbal, A, Lishner, M, Elis, A, Lugassy, G, Varon, D, Zeltser, D, Rogowski, O, Steinvil, A, Zisman, D, Ageno, W, Ambrosio, G, Cattaneo, M, D'Angelo, A, Ghirarduzzi, A, Lotti, M, Pierfranceschi, Mg, Lodigiani, C, Palareti, G, Barone, M, Beltrametti, C, Porreca, E, Prandoni, Paolo, Spiezia, L, Quintavalla, R, Cho, Wh, Ha, Jw, Kim, Hs, Park, K, Sime, I, Miliauskas, S, Petrauskiene, R, Sathar, J, Beeker, A, Ten Cate, H, De Groot, M, Kamphuisen, P, Douma, R, Kooy, Mv, Coenen, J, Mäkelburg, A, Knol, M, Tichelaar, V, Harper, P, Knottenbelt, E, Ockelford, P, Young, L, Royle, G, Simpson, D, Chunilal, S, Ghanima, W, Foyn, S, Tveit, A, Abola, Mt, Adamiec, R, Gorski, P, Kloczko, J, Lewczuk, J, Nowak, M, Musial, J, Wronski, J, Ng, Hj, Adler, D, Becker, Jh, Ellis, G, Isaacs, R, Bloy, B, Allie, R, Eckstein, F, van Rensburg JH, Schmidt, S, Siebert, H, Zyl, L, Carrera, M, Del Campo, F, Diego, I, Garcia Bragado, F, Jiménez, D, Sánchez Álvarez, J, Redondo, M, Roman Sanchez, P, Villalta, J, Villegas Scivetti, M, Jonson, T, Tygesen, H, Lapidus, L, Ottosson, E, Själander, A, Asmis, L, Banyai, M, Heidemann, M, Baumgartner, I, Righini, M, Frank, U, Hayoz, D, Periard, D, Chang, Wt, Chiu, K, Wang, Ky, Weng, Zc, Angchaisuksiri, P, Pothirat, C, Rojnuckarin, P, Solis, J, Hunt, B, Luckit, J, Albrecht, C, Banish, D, Feinbloom, D, Botnick, W, Chen, D, Dexter, J, Ettinger, N, Gleeson, J, Jaffer, A, Joseph, S, Kennedy, M, Krell, K, Lavender, R, Lyons, R, Moll, S, Nadar, V, Darrow, K, Hardman, V, Rathbun, S, Rehm, J, Rodriguez Cintron, W, Stevens, K, Wright, P, Ramaswamy, M., ACS - Amsterdam Cardiovascular Sciences, Vascular Medicine, Other departments, Epidemiologie, MUMC+: KIO Kemta (9), RS: CAPHRI School for Public Health and Primary Care, Department of Vascular Medicine (DVM - AMC), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), Department of Epidemiology (MHP), Maastricht University [Maastricht], Groupe de recherche sur la thrombose (GRT (EA 3065)), Université Jean Monnet [Saint-Étienne] (UJM), Service d'angiologie et d'hémostase (MR), Hôpital Universitaire de Genève, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), and Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
MESH: Pulmonary Embolism, Male, Vitamin K, Administration, Oral, Pulmonary Embolism/drug therapy/mortality, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Rivaroxaban, Edoxaban, Recurrence, Hemorrhage/chemically induced, 030212 general & internal medicine, Vitamin K/antagonists & inhibitors, Enoxaparin/adverse effects/therapeutic use, MESH: Treatment Outcome, MESH: Aged, ddc:616, MESH: Middle Aged, Hazard ratio, General Medicine, MESH: Follow-Up Studies, Vitamin K antagonist, MESH: Thiophenes, Middle Aged, Thrombosis, Morpholines/adverse effects/therapeutic use, 3. Good health, Pulmonary embolism, MESH: International Normalized Ratio, Treatment Outcome, Anesthesia, MESH: Administration, Oral, Administration, Combination, Apixaban, Drug Therapy, Combination, Female, MESH: Hemorrhage, medicine.drug, Oral, MESH: Enoxaparin, medicine.drug_class, Morpholines, Anticoagulants/adverse effects/therapeutic use, MESH: Morpholines, Hemorrhage, Thiophenes, MESH: Anticoagulants, 03 medical and health sciences, Drug Therapy, medicine, Humans, International Normalized Ratio, Enoxaparin, MESH: Kaplan-Meier Estimate, Aged, MESH: Humans, business.industry, MESH: Vitamin K, Anticoagulants, medicine.disease, MESH: Male, MESH: Recurrence, Regimen, MESH: Drug Therapy, Combination, chemistry, Thiophenes/adverse effects/therapeutic use, business, Pulmonary Embolism, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Follow-Up Studies
Abstract

International audience; BACKGROUND: A fixed-dose regimen of rivaroxaban, an oral factor Xa inhibitor, has been shown to be as effective as standard anticoagulant therapy for the treatment of deep-vein thrombosis, without the need for laboratory monitoring. This approach may also simplify the treatment of pulmonary embolism. METHODS: In a randomized, open-label, event-driven, noninferiority trial involving 4832 patients who had acute symptomatic pulmonary embolism with or without deep-vein thrombosis, we compared rivaroxaban (15 mg twice daily for 3 weeks, followed by 20 mg once daily) with standard therapy with enoxaparin followed by an adjusted-dose vitamin K antagonist for 3, 6, or 12 months. The primary efficacy outcome was symptomatic recurrent venous thromboembolism. The principal safety outcome was major or clinically relevant nonmajor bleeding. RESULTS: Rivaroxaban was noninferior to standard therapy (noninferiority margin, 2.0; P=0.003) for the primary efficacy outcome, with 50 events in the rivaroxaban group (2.1%) versus 44 events in the standard-therapy group (1.8%) (hazard ratio, 1.12; 95% confidence interval [CI], 0.75 to 1.68). The principal safety outcome occurred in 10.3% of patients in the rivaroxaban group and 11.4% of those in the standard-therapy group (hazard ratio, 0.90; 95% CI, 0.76 to 1.07; P=0.23). Major bleeding was observed in 26 patients (1.1%) in the rivaroxaban group and 52 patients (2.2%) in the standard-therapy group (hazard ratio, 0.49; 95% CI, 0.31 to 0.79; P=0.003). Rates of other adverse events were similar in the two groups. CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile. (Funded by Bayer HealthCare and Janssen Pharmaceuticals; EINSTEIN-PE ClinicalTrials.gov number, NCT00439777.).

Published
2012

43. [Prevention of deep venous thrombosis in medical care]

Author

Francis Couturaud, Leroyer C, Le Moigne E, Oger E, Mottier D, Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), and Calvez, Ghislaine

Subjects
Risk, Clinical Trials as Topic, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Humans, MESH: Risk, MESH: Clinical Trials as Topic, Thrombophlebitis, Cross-Sectional Studies, MESH: Cross-Sectional Studies, MESH: Thrombophlebitis, Humans, Longitudinal Studies, MESH: Longitudinal Studies, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; Venous thromboembolism is a frequent and potentially severe ailment in medical patients; the clinical signs are unreliable and as early detection of the thrombosis process by non-invasive techniques is not available, prevention appears to be an alternative. Careful definition of the medical situations at risk from venous thromboembolism is necessary. Age, prior history of venous thromboembolism, and immobilization constitute high risk circumstances. Analysis of the published studies advocates prevention in three circumstances: myocardial infarction, stroke and intensive care. In other cases, further controlled studies, randomized versus placebo, are needed.

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results